Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IBTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP6AP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WWP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRMS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAP29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JKAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KPNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIOK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLAA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUL4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIN7C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACADM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTUD6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP13A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on